UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Automation of sample preparation for mass cytometry barcoding in support of clinical research: protocol optimization

Analytical and bioanalytical chemistry, 2017-03, Vol.409 (9), p.2363-2372

2017

Volltextzugriff (PDF)

Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer

Metabolites, 2024-05, Vol.14 (6), p.314

2024

Volltextzugriff (PDF)

Is Lipid Metabolism of Value in Cancer Research and Treatment? Part I- Lipid Metabolism in Cancer

Metabolites, 2024-05, Vol.14 (6), p.312

2024

Volltextzugriff (PDF)

UPLC–MS for metabolomics: a giant step forward in support of pharmaceutical research

Drug discovery today, 2017-02, Vol.22 (2), p.463-470

2017

Volltextzugriff (PDF)

Mass cytometry moving forward in support of clinical research: advantages and considerations

Bioanalysis, 2016-02, Vol.8 (4), p.255-257

2016

Volltextzugriff (PDF)

Rapid label-free profiling of oral cancer biomarker proteins using nano-UPLC-Q-TOF ion mobility mass spectrometry

Proteomics. Clinical applications, 2016-03, Vol.10 (3), p.280-289

2016

Volltextzugriff (PDF)

A Burned-Out CD8 + T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy

Cancer discovery, 2021-07, Vol.11 (7), p.1700-1715

2021

Volltextzugriff (PDF)

Drug Metabolism Handbook: Concepts and Applications in Cancer Research

2, 2022

Volltextzugriff (PDF)

Biotransformation and Metabolite Elucidation of Xenobiotics: Characterization and Identification

Nassar, Ala F

1. Aufl., 2010

Volltextzugriff (PDF)

Dilysine-Methylene Diphenyl Diisocyanate (MDI), a Urine Biomarker of MDI Exposure?

Chemical research in toxicology, 2019-04, Vol.32 (4), p.557-565

2019

Volltextzugriff (PDF)

Impact of recent innovations in the use of mass cytometry in support of drug development

Drug discovery today, 2015-10, Vol.20 (10), p.1169-1175

2015

Volltextzugriff (PDF)

Polymerization of hexamethylene diisocyanate in solution and a 260.23 m/z [M+H]+ ion in exposed human cells

Analytical biochemistry, 2018-02, Vol.543, p.21-29

2018

Volltextzugriff (PDF)

In vitro cleavage of diisocyanate-glutathione conjugates by human gamma-glutamyl transpeptidase-1

Xenobiotica, 2016-08, Vol.46 (8), p.726-732

2016

Volltextzugriff (PDF)

Metabolic disposition of the anti-cancer agent [14C]laromustine in male rats

Xenobiotica, 2015-08, Vol.45 (8), p.711-721

2015

Volltextzugriff (PDF)

Population pharmacokinetic (PK) analysis of laromustine, an emerging alkylating agent, in cancer patients

Xenobiotica, 2017-05, Vol.47 (5), p.394-407

2017

Volltextzugriff (PDF)

Progress in automation of mass cytometry barcoding for drug development

Bioanalysis, 2016-07, Vol.8 (14), p.1429-1435

2016

Volltextzugriff (PDF)

Development and Validation of LC-MS-MS Assay for the Determination of the Emerging Alkylating Agent Laromustine and Its Active Metabolite in Human Plasma

Journal of chromatographic science, 2019-03, Vol.57 (3), p.195-203

2019

Volltextzugriff (PDF)

Reaction products of hexamethylene diisocyanate vapors with "self" molecules in the airways of rabbits exposed via tracheostomy

Xenobiotica, 2018-05, Vol.48 (5), p.488-497

2018

Volltextzugriff (PDF)

Drug metabolism handbook: concepts and applications

1, 2009

Volltextzugriff (PDF)

Di-Lysine-Methylene Diphenyl Diisocyanate (MDI), a Urine Biomarker of MDI Exposure?

Chemical research in toxicology, 2019-02, Vol.32 (4), p.557-565

2019

Volltextzugriff (PDF)

Role of Structural Modifications of Drug Candidates to Enhance Metabolic Stability

Drug Metabolism Handbook, 2022, p.303-322

2022

Volltextzugriff (PDF)

Accelerating Metabolite Identification Mass Spectrometry Technology Drives Metabolite Identification Studies Forward

Drug Metabolism Handbook, 2022, p.267-302

2022

Volltextzugriff (PDF)

Drug Design Strategies: Role of Structural Modifications of Drug Candidates to Improve PK Parameters of New Drugs

Drug Metabolism Handbook, 2022, p.323-343

2022

Volltextzugriff (PDF)

Chemical Structural Alert and Reactive Metabolite Concept as Applied in Medicinal Chemistry to Minimize the Toxicity of Drug Candidates

Drug Metabolism Handbook, 2022, p.345-372

2022

Volltextzugriff (PDF)

Case Study: Metabolism and Reactions of Alkylating Agents in Cancer Therapy

Drug Metabolism Handbook, 2022, p.893-922

2022

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(96)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Automation of sample preparation for mass cytometry barcoding in support of clinical research: protocol optimization

Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer

Is Lipid Metabolism of Value in Cancer Research and Treatment? Part I- Lipid Metabolism in Cancer

UPLC–MS for metabolomics: a giant step forward in support of pharmaceutical research

Mass cytometry moving forward in support of clinical research: advantages and considerations

Rapid label-free profiling of oral cancer biomarker proteins using nano-UPLC-Q-TOF ion mobility mass spectrometry

A Burned-Out CD8 + T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy

Drug Metabolism Handbook: Concepts and Applications in Cancer Research

Biotransformation and Metabolite Elucidation of Xenobiotics: Characterization and Identification

Dilysine-Methylene Diphenyl Diisocyanate (MDI), a Urine Biomarker of MDI Exposure?

Impact of recent innovations in the use of mass cytometry in support of drug development

Polymerization of hexamethylene diisocyanate in solution and a 260.23 m/z [M+H]+ ion in exposed human cells

In vitro cleavage of diisocyanate-glutathione conjugates by human gamma-glutamyl transpeptidase-1

Metabolic disposition of the anti-cancer agent [14C]laromustine in male rats

Population pharmacokinetic (PK) analysis of laromustine, an emerging alkylating agent, in cancer patients

Progress in automation of mass cytometry barcoding for drug development

Development and Validation of LC-MS-MS Assay for the Determination of the Emerging Alkylating Agent Laromustine and Its Active Metabolite in Human Plasma

Reaction products of hexamethylene diisocyanate vapors with "self" molecules in the airways of rabbits exposed via tracheostomy

Drug metabolism handbook: concepts and applications

Di-Lysine-Methylene Diphenyl Diisocyanate (MDI), a Urine Biomarker of MDI Exposure?

Role of Structural Modifications of Drug Candidates to Enhance Metabolic Stability

Accelerating Metabolite Identification Mass Spectrometry Technology Drives Metabolite Identification Studies Forward

Drug Design Strategies: Role of Structural Modifications of Drug Candidates to Improve PK Parameters of New Drugs

Chemical Structural Alert and Reactive Metabolite Concept as Applied in Medicinal Chemistry to Minimize the Toxicity of Drug Candidates

Case Study: Metabolism and Reactions of Alkylating Agents in Cancer Therapy

Suchergebnisse filtern